🇺🇸 FDA

Drug profile · INN

ensifentrine

OHTUVAYRE

FDA: approved EMA: application withdrawn R03BX
US status
approved
Patents linked
0
News articles
0

Quick answer

ensifentrine (OHTUVAYRE) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

Key facts

INN ensifentrine
Brand OHTUVAYRE
Route INHALATION
Formulation SUSPENSION
ATC code R03BX

Frequently asked questions

What is ensifentrine?

ensifentrine (OHTUVAYRE) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

What is the brand name for ensifentrine?

OHTUVAYRE is a marketed brand name for ensifentrine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ensifentrine?

ensifentrine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.